Sexually transmitted diseases treatment guidelines (2015)
Kimberly A. Workowski,Gail Bolan +1 more
Reads0
Chats0
TLDR
In this paper, the authors describe the genitalia of Neisseria gonorrhoeae as a "Neisseria genitalium" and use it to develop Mycoplasma genitalium.Abstract:
Дані рекомендації щодо лікування осіб, які мають або піддаються ризику захворювань, що передаються статевим шляхом (ЗПСШ), були оновлені Центрами з контролю і профілактики захворювань США після консультації з групою фахівців у сфері ЗПСШ, які зустрілися в Атланті навесні 2013 р. Це оновлена версія Керівництва з лікування ЗПСШ від 2010 р. В оновленій версії керівництва обговорюються: 1) альтернативні схеми лікування Neisseria gonorrhoeae; 2) застосування методів ампліфікації нуклеїнових кислот для діагностики трихомоніазу; 3) альтернативні способи лікування гострих кондилом; 4) роль Mycoplasma genitalium у розвитку уретритів/цервіцитів і наслідки, пов’язані з лікуванням; 5) оновлені рекомендації з консультування та вакцинації проти вірусу папіломи людини; 6) менеджмент пацієнтів-транссексуалів; 7) щорічне тестування на гепатит С осіб із ВІЛ-інфекцією; 8) оновлені рекомендації з діагностичної оцінки уретриту; 9) повторне тестування з метою виявлення нового інфікування. Дане керівництво можуть використовувати лікарі та інші медичні працівники для надання допомоги з профілактики та лікування ЗПСШ.read more
Citations
More filters
Journal ArticleDOI
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
Lori M. Newman,Jane Rowley,Stephen Vander Hoorn,Stephen Vander Hoorn,Nalinka Saman Wijesooriya,Magnus Unemo,Nicola Low,Gretchen A Stevens,Sami L Gottlieb,James Kiarie,Marleen Temmerman +10 more
TL;DR: Estimates of the global prevalence and incidence of chlamydia, gonorrhoea, trichomoniasis, and syphilis in adult women and men remain high, with nearly one million new infections with curable STI each day.
Journal ArticleDOI
Approved Antiviral Drugs over the Past 50 Years
TL;DR: This paper presents for the first time a comprehensive overview of antiviral drugs approved over the past 50 years, shedding light on the development of effective antiviral treatments against current and emerging infectious diseases worldwide.
Journal ArticleDOI
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel
Huldrych F. Günthard,Michael S. Saag,Constance A. Benson,Carlos del Rio,Joseph J. Eron,Joel E. Gallant,Jennifer F Hoy,Michael J. Mugavero,Paul E. Sax,Melanie A. Thompson,Rajesh T. Gandhi,Raphael J. Landovitz,Davey M. Smith,Donna M. Jacobsen,Paul A. Volberding +14 more
TL;DR: In this article, the authors provide updated recommendations for the use of antiretroviral therapy in adults (aged ≥18 years) with established HIV infection, including when to start treatment, initial regimens, and changing regimens along with recommendations for using ARVs for preventing HIV among those at risk, including preexposure and postexposure prophylaxis.
Journal ArticleDOI
Sexually Transmitted Infections Treatment Guidelines,2021
Kimberly A. Workowski,Laura H. Bachmann,Philip A. Chan,Christine Johnston,Christina A. Muzny,Ina U. Park,Hilary Reno,Jonathan M. Zenilman,Gail Bolan +8 more
TL;DR: These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019.
Journal ArticleDOI
Sexually transmitted infections: challenges ahead
Magnus Unemo,Catriona S. Bradshaw,Jane S Hocking,Henry J. C. de Vries,Suzanna C. Francis,David Mabey,Jeanne M. Marrazzo,Gerard J.B. Sonder,Jane R. Schwebke,Elske Hoornenborg,Rosanna W. Peeling,Susan S. Philip,Nicola Low,Christopher K Fairley +13 more
TL;DR: Overall, this Commission aims to enhance the understanding of some of the key challenges facing the field of STI treatment and control, and outlines new approaches to improve the clinical management of STIs and public health.
References
More filters
Journal ArticleDOI
Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.
Catherine L. Satterwhite,Elizabeth Torrone,Elissa Meites,Eileen F. Dunne,Reena Mahajan,M. Cheryl Bañez Ocfemia,John R. Su,Fujie Xu,Hillard Weinstock +8 more
TL;DR: Sexually transmitted infections are common in the United States, with a disproportionate burden among young adolescents and adults, and public health efforts should focus on prevention among at-risk populations to reduce the number and impact of STIs.
Journal ArticleDOI
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.
Mary Frances Cotch,J G Pastorek nd,Robert P. Nugent,Sharon L. Hillier,Sharon L. Hillier,Ronald S. Gibbs,David H. Martin,David A. Eschenbach,Robert R. Edelman,Robert R. Edelman,J C Carey,Joan A. Regan,Marijane A. Krohn,Marijane A. Krohn,Mark A. Klebanoff,A V Rao,George G. Rhoads +16 more
TL;DR: After considering other recognized risk factors including co‐infections, pregnant women infected with T. vaginalis at mid‐gestation were statistically significantly more likely to have a low birth weight infant, to deliver preterm, and to have an preterm low birth Weight infant.
Journal ArticleDOI
High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
Magnus Unemo,Daniel Golparian,Robert A. Nicholas,Makoto Ohnishi,Anne Gallay,Patrice Sednaoui +5 more
TL;DR: F89 has high-level resistance to cefixime and ceftriaxone and resistance to most other antimicrobials examined and is assigned to MLST sequence type 1901 and NG-MAST ST1407, which is a successful gonococcal clone that has spread globally.
Journal ArticleDOI
A newly discovered mycoplasma in the human urogenital tract.
TL;DR: Although the data are insufficient to implicate the new mycoplasmas in human disease, the fact that they are unique, extremely fastidious, and have adherence properties, has stimulated efforts to assess their pathogenicity and possible role in human urogenital disease.
Journal ArticleDOI
The Prevalence of Trichomonas vaginalis Infection among Reproductive-Age Women in the United States, 2001–2004
Madeline Y. Sutton,Maya R. Sternberg,Emilia H. Koumans,Geraldine M. McQuillan,Stuart M. Berman,Lauri E. Markowitz +5 more
TL;DR: A significant racial disparity exists; the prevalence among non-Hispanic black women was 10.3 times higher than that amongnon-Hispanic white and Mexican American women, and Optimal prevention and control strategies for T. vaginalis infection should be explored as a means of closing the racial disparity gaps and decreasing adverse health outcomes.